OrbiMed’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

OrbiMed’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,785,714	Closed	-$22.6M	–	145
2014 Q3	$22.6M	Hold	1,785,714	–	–	0.24%	71
2014 Q2	$30.4M	Hold	1,785,714	–	–	0.36%	53
2014 Q1	$24M	Hold	1,785,714	–	–	0.3%	60
2013 Q4	$22.8M	Hold	1,785,714	–	–	0.34%	60
2013 Q3	$16.1M	Hold	1,785,714	–	–	0.29%	62
2013 Q2	$12.9M	Buy	+1,785,714	New	+$13.1M	0.27%	66

OrbiMed's DRTX Position: Q4 2014 in Review

OrbiMed sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 1,785,714 shares — an estimated $22.6M sold.

OrbiMed first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $30.4M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

OrbiMed reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
OrbiMed sold 1,785,714 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $22.6M.
OrbiMed first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
OrbiMed's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $30.4M in Q2 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on OrbiMed's 13F filing for Q4 2014, filed 13 Feb 2015.